Cite
HARVARD Citation
Panday, N. et al. (2021). Metabolite profiling of IMID‐2, a novel anticancer molecule of piperazine derivative: In silico prediction, in vitro and in vivo metabolite characterization using UPLC–QTOF–MS/MS. Biomedical chromatography. p. n/a. [Online].